Public release date: 25-Nov-2009
New approach reprograms the mammalian immune system to attack tumors body-wide
CAMBRIDGE, Mass. — A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, scientists report this week in the journal Science Translational Medicine.
The new approach, pioneered by bioengineers and immunologists at Harvard University, uses plastic disks impregnated with tumor-specific antigens and implanted under the skin to reprogram the mammalian immune system to attack tumors.
http://www.eurekalert.org/pub_releases/2009-11/hu-icv112009.php
{ 0 comments }
